These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein. Lin HL, Zhang H, Noon KR, Hollenberg PF. J Pharmacol Exp Ther; 2009 Nov; 331(2):392-403. PubMed ID: 19700628 [Abstract] [Full Text] [Related]
8. Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6. Kent UM, Lin HL, Mills DE, Regal KA, Hollenberg PF. Chem Res Toxicol; 2006 Feb; 19(2):279-87. PubMed ID: 16485904 [Abstract] [Full Text] [Related]
9. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486). He K, Woolf TF, Hollenberg PF. J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590 [Abstract] [Full Text] [Related]
10. The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir. Lin HL, D'Agostino J, Kenaan C, Calinski D, Hollenberg PF. Drug Metab Dispos; 2013 Oct; 41(10):1813-24. PubMed ID: 23886699 [Abstract] [Full Text] [Related]
15. The functional role of threonine-205 in the mechanism-based inactivation of P450 2B1 by two ethynyl substrates: the importance of the F helix in catalysis. Lin HL, Kent UM, Zhang H, Waskell L, Hollenberg PF. J Pharmacol Exp Ther; 2004 Dec; 311(3):855-63. PubMed ID: 15302894 [Abstract] [Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P450 2B4 by aldehydes: relationship to aldehyde deformylation via a peroxyhemiacetal intermediate. Raner GM, Chiang EW, Vaz AD, Coon MJ. Biochemistry; 1997 Apr 22; 36(16):4895-902. PubMed ID: 9125510 [Abstract] [Full Text] [Related]
17. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. Kent UM, Mills DE, Rajnarayanan RV, Alworth WL, Hollenberg PF. J Pharmacol Exp Ther; 2002 Feb 22; 300(2):549-58. PubMed ID: 11805216 [Abstract] [Full Text] [Related]
18. Spectral studies of tert-butyl isothiocyanate-inactivated P450 2E1. Kent UM, Roberts-Kirchhoff ES, Moon N, Dunham WR, Hollenberg PF. Biochemistry; 2001 Jun 19; 40(24):7253-61. PubMed ID: 11401573 [Abstract] [Full Text] [Related]
19. One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac. Boerma JS, Vermeulen NP, Commandeur JN. Chem Biol Interact; 2014 Jan 25; 207():32-40. PubMed ID: 24246759 [Abstract] [Full Text] [Related]
20. Mechanism-based inactivation of cytochrome P450 2D6 by 1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: kinetic characterization and evidence for apoprotein adduction. Hutzler JM, Steenwyk RC, Smith EB, Walker GS, Wienkers LC. Chem Res Toxicol; 2004 Feb 25; 17(2):174-84. PubMed ID: 14967005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]